Clients News • MC Services corporate website
5522
page-template-default,page,page-id-5522,bridge-core-2.1.4,qode-listing-1.0.1,qode-social-login-1.0,qode-quick-links-1.0,ajax_fade,page_not_loaded,,qode-title-hidden,paspartu_enabled,qode_grid_1400,footer_responsive_adv,qode-content-sidebar-responsive,qode-child-theme-ver-1.0.0,qode-theme-ver-20.1,qode-theme-bridge,disabled_footer_top,qode_header_in_grid,bridge-child,wpb-js-composer js-comp-ver-6.7.0,vc_responsive

CLIENT NEWS

 

 

  • EsoCap secures new funding
    www.esocapbiotech.ch
  • InflaRx to Present at H.C. Wainwright 7th Annual Israel Conference
    www.inflarx.de
  • Secarna Pharmaceuticals and Achilles Therapeutics sign research, option and license agreement to develop optimized T cell therapies
    www.secarna.com
  • MagForce AG: MagForce USA, Inc. has Received FDA’s Approval to Proceed with Stage 2B with the Final Protocol of the Pivotal U.S. Study for the Focal Ablation of Prostate Cancer with the NanoTherm Therapy System
    www.magforce.de
  • InflaRx Reports Third Quarter 2021 Financial & Operating Results
    www.inflarx.de
  • HepaRegeniX to present key results on MKK4 inhibitors and their therapeutic efficacy at upcoming scientific conferences
    www.heparegenix.com/
  • Imcyse Appoints Gene Mack, MBA as Chief Financial Officer
    www.imcyse.com
  • XPhyto Announces Managing Director Appointment, Financing and 3a-diagnostics Development
    www.xphyto.com
  • MagForce AG Publishes Financial Results for H1/2021 and Operative Highlights
    www.magforce.de
  • Temedica Appoints Dr Christina Wagner as Chief Financial Officer
    www.temedica.com